John Libbey Eurotext

Médecine et Santé Tropicales

Panorama des poxvirus : émergence du monkeypox Volume 27, numéro 1, Janvier-Février-Mars 2017

  • [1] Diven D.G. An overview of poxviruses. J Am Acad Dermatol. 2001;44:1-16.
  • [2] Duraffour S, Ferraris O, Nicolas Peyrefitte C. Cowpox et monkeypox. EMC (Elsevier Masson SAS, Paris), Maladies infectieuses. 2016 ; 13 : 1-10 [Article 8-050-M-10]
  • [3] Breman J.G., Nakano J.H., Coffi E., Godfrey H., Gautun J.C. Human poxvirus disease after smallpox eradication. Am J Trop Med Hyg. 1977;26:273-281.
  • [4] Rimoin A.W., Mulembakani P.M., Johnston S.C. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc Natl Acad Sci USA. 2010;107:16262-16267.
  • [5] Ladnyj I.D., Ziegler P., Kima E. À human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo. Bull World Health Organ. 1972;46:593-597.
  • [6] Jezek Z., Szczeniowski M., Paluku K.M., Mutombo M. Human monkeypox : clinical features of 282 patients. J Infect Dis. 1987;156:293-298.
  • [7] Meyer A., Esposito J.J., Gras F. Première apparition au Gabon du monkey pox chez l’homme. Med Trop. 1991;51:53-57.
  • [8] Heymann D.L., Szczeniowski M., Esteves K. Reemergence of monkeypox in Africa : a review of the past six years. Br Med Bull. 1998;54:693.
  • [9] Hutin Y.J., Williams R.J., Malfait P. Outbreak of human monkeypox, Democratic Republic of Congo, 1996 to 1997. Emerg Infect Dis. 2001;7:434.
  • [10] Di Giulio D.B., Eckburg P.B. Human monkeypox. Lancet Infect Dis. 2004;4:199.
  • [11] Fleischauer A.T., Kile J.C., Davidson M. Evaluation of human-to-human transmission of monkeypox from infected patients to health care workers. Clin Infect Dis. 2005;40:689.
  • [12] Huhn G.D., Bauer A.M., Yorita K. Clinical characteristics of human monkeypox, and risk factors for severe disease. Clin Infect Dis. 2005;41:1742.
  • [13] Nalca A., Rimoin A.W., Bavari S., Whitehouse C.A. Reemergence of monkeypox : prevalence, diagnostics and countermeasures. Clin Infect Dis. 2005;41:1765.
  • [14] Likos A.M., Sammons S.A., Olson V.A. À tale of two clades : monkeypox viruses. J Gen Virol. 2005;86:2661.
  • [15] Chen N., Li G., Liszewski M.K. Virulence differences between monkeypox virus isolates from West Africa and the Congo basin. Virology. 2005;340:46.
  • [16] Nakazawa Y., Mauldin M.R., Emerson G.L. À phylogeographic investigation of African monkeypox. Viruses. 2015;7:2168-2184.
  • [17] Learned L.A., Reynolds M.G., Wassa D.W. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg. 2005;73:428-434.
  • [18] Formenty P., Muntasir M.O., Damon I. Human monkeypox outbreak caused by novel virus belonging to Congo Basin clade, Sudan, 2005. Emerg Infect Dis. 2010;16:1539-1545.
  • [19] McCollum A.M., Damon I.K. Human monkeypox. Clin Infect Dis. 2014;58:260-267.
  • [20] McCollum A.M., Nakazawa Y., Ndongala G.M. Human Monkeypox in the Kivus, a Conflict Region of the Democratic Republic of the Congo. Am J Trop Med Hyg. 2015;93:718-721.
  • [21] Nolen L.D., Osadebe L., Katomba J. Extended Human-to-Human Transmission during a Monkeypox Outbreak in the Democratic Republic of the Congo. Emerg Infect Dis. 2016;22:1014-1021.
  • [22] Centers for Disease Control and Prevention (CDC). Update : multistate outbreak of monkeypox-Illinois, Indiana, Kansas, Missouri Ohio, and Wisconsin, 2003. Morb Mortal Wkly Rep. 2003;52:642.
  • [23] Reynolds M.G., Davidson W.B., Curns A.T. Spectrum of infection and risk factors for human monkeypox, United States, 2003. Emerg Infect Dis. 2007;13:1332.
  • [24] Sale T.A., Melski J.W., Stratman E.J. Monkeypox : an epidemiologic and clinical comparison of African and US disease. J Am Acad Dermatol. 2006;55:478-481.
  • [25] Jezek Z., Arita I., Szczeniowski M. Human Tanapox in Zaire : clinical and epidemiological observations on cases confirmed by laboratory studies. Bull World Health Organ. 1985;63:1027-1035.
  • [26] Stich A., Meyer H., Kohler B., Fleischer K. Tanapox : first report in a European traveler and identification by PCR. Trans R Soc Trop Med Hyg. 2002;96:178-179.
  • [27] Morand J.J. La varicelle comporte-t-elle une atteinte palmo-plantaire ? Ann Dermatol Venereol. 2012;139:227-228.
  • [28] Bayer-Garner I.B. Monkeypox virus : histologic, immunohistochemical and electron- microscopic findings. Cutan Pathol. 2005;32:28.
  • [29] Karem K.L., Reynolds M., Braden Z. Characterization of acute-phase humoral immunity to monkeypox : use of immunoglobulin M enzyme-linked immunosorbent assay for detection of monkeypox infection during the 2003 North American outbreak. Clin Diagn Lab Immunol. 2005;12:867.
  • [30] Olson V.A., Laue T., Laker M.T. Real-time PCR system for detection of orthopoxviruses and simultaneous identification of smallpox virus. J Clin Microbiol. 2004;42:1940-1946.
  • [31] Zhao H., Wilkins K., Damon I.K., Li Y. Specific qPCR assays for the detection of orf virus, pseudocowpox virus and bovine papular stomatitis virus. J Virol Methods. 2013;194:229-234.
  • [32] Babkin I.V., Babkina I.N. The Origin of the Variola Virus. Viruses. 2015;7:1100-1112.
  • [33] Garin D. Orthopoxvirus : variole et vaccine. EMC (Elsevier Masson SAS, Paris), Maladies infectieuses. 2014 : 8-050-J-10.
  • [34] Henderson D.A., Arita I. The smallpox threat : a time to reconsider global policy. Biosecur Bioterror. 2014;12:117-121.
  • [35] Kerrod E., Geddes A.M., Regan M., Leach S., Surveillance. Control Measures during Smallpox Outbreaks. Emerging Infect Dis. 2005;11:291-297.
  • [36] Essbauer S., Pfeffer M., Meyer H. Zoonotic poxviruses. Vet Microbiol. 2010;140:229-236.
  • [37] Trindade G.S., Emerson G.L., Carroll D.S., Kroon E.G., Damon I.K. Brazilian vaccinia viruses and their origins. Emerg Infect Dis. 2007;13:965-972.
  • [38] Singh R.K., Hosamani M., Balamurugan V. Buffalopox : an emerging and re-emerging zoonosis. Anim Health Res Rev. 2007;8:105-114.
  • [39] Yutu J.A., Jing M., Guang X.H. Outbreaks of smallpox due to variolation in China, 1962-1965. Am J Epidemiol. 1988;128:39-45.
  • [40] Greenberg R.N., Kennedy J.S. ACAM2000 : a newly licensed cell culturebased live vaccinia smallpox vaccine. Expert Opin Investig Drugs. 2008;17:555-564.
  • [41] Lane J.M., Ruben F.L., Neff J.M., Millar J.D. Complications of smallpox vaccination, 1968 : results of ten statewide surveys. J Infect Dis. 1970;122:303-309.
  • [42] Moussatché N., Tuyama M., Kato S.E. Accidental infection of laboratory worker with vaccinia virus. Emerg Infect Dis. 2003;9:724-726.
  • [43] Miller J.R., Cirino N.M., Philbin E.F. Generalized vaccinia 2 days after smallpox revaccination. Emerg Infect Dis. 2003;9:1649-1650.
  • [44] Petersen B.W., Harms T.J., Reynolds M.G., Harrison L.H. Use of Vaccinia virus Smallpox Vaccine in Laboratory and Health care personnel at risk for occupational Exposure to Orthopoxviruses. Morb Mortal Wkly Rep. 2016;65:257-262.
  • [45] Baxby D., Bennett M., Getty B. Human cowpox 1969-93 : a review based on 54 cases. Br J Dermatol. 1994;131:598-607.
  • [46] Pelkonen P.M., Tarvainen K., Hynninen A. Cowpox with severe generalized eruption, Finland. Emerg Infect Dis. 2003;9:1458-1461.
  • [47] Kurth A., Wibbelt G., Gerber H.P. Rat-to-elephant-to-human transmission of cowpox virus. Emerg Infect Dis. 2008;14:670-671.
  • [48] Campe H., Zimmermann P., Glos K. Cowpox virus transmission from pet rats to humans, Germany. Emerg Infect Dis. 2009;15:777-780.
  • [49] Ninove L., Domart Y., Vervel C. Cowpox virus transmission from pet rats to humans, France. Emerg Infect Dis. 2009;15:781-784.
  • [50] Strenger V., Muller M., Richter S. À 17-year-old girl with a black eschar. Cowpox virus infection. Clin Infect Dis. 2009;48:91-94.
  • [51] Elsendoorn A., Agius G., Le Moal G. Severe ear chondritis due to cowpox virus transmitted by a pet rat. J Infect. 2011;63:391-393.
  • [52] McCollum A.M., Austin C., Nawrocki J. Investigation of the first laboratory-acquired human cowpox virus infection in the United States. J Infect Dis. 2012;206:63-68.
  • [53] Duraffour S., Mertens B., Meyer H. Emergence of Cowpox : Study of the Virulence of Clinical Strains and Evaluation of Antivirals. PLoS ONE. 2013;8:e55808.
  • [54] Robinson A.J., Peterson G.V. Orf virus infection of workers in the meat industry. N Z Med J. 1983;96:81-85.
  • [55] Nougairede A., Fossati C., Salez N. Sheep-to-human transmission of Orf virus during Eid al-Adha religious practices, France. Emerg Infect Dis. 2013;19:102-105.
  • [56] Yirrell D.L., Vestey J.P. Human orf infections. J Eur Acad Dermatol Venereol. 1994;3:451-459.
  • [57] Leavell U.W., McNamara M.J., Muelling R. Orf : report of 19 human cases with clinical and pathological observations. JAMA. 1968;204:657-664.
  • [58] McCabe D., Weston B., Storch G. Treatment of orf poxvirus lesion with cidofovir cream. Pediatr Infect Dis J. 2003;22:1027-1028.
  • [59] Erbagci Z., Erbagci I., Almila Tuncel A. Rapid improvement of human orf (ecthyma contagiosum) with topical imiquimod cream : report of four complicated cases. J Dermatol Treat. 2005;16:353-356.
  • [60] Nollens H.H., Gulland F.M., Jacobson E.R. Parapoxviruses of seals and sea lions make up a distinct subclade within the genus Parapoxvirus. Virology. 2006;349:316-324.
  • [61] Roess A.A., Galan A., Kitces E. Novel deer-associated parapoxvirus infection in deer hunters. N Engl J Med. 2010;363:2621-2627.
  • [62] Chen X., Anstey A.V., Bugert J.J. Molluscum contagiosum virus infection. Lancet Infect Dis. 2013;13:877-888.
  • [63] Osio A., Deslandes E., Saada V., Morel P., Guibal F. Clinical characteristics of molluscum contagiosum in children in a private dermatology practice in the greater Paris area France : a prospective study in 661 patients. Dermatology. 2011;222:314-320.
  • [64] Molina L., Romiti R. Molluscum contagiosum on tattoo. An Bras Dermatol. 2011;86:352-354.
  • [65] Thompson A.J., Matinpour K., Hardin J., Hsu S. Molluscum gladiatorum. Dermatol Online J. 2014;20:6.
  • [66] McCollum A.M., Holman R.C., Hughes C.M. Molluscum contagiosum in a pediatric American Indian population : incidence and risk factors. PLoS One. 2014;9:e103419.
  • [67] Olsen J.R., Piguet V., Gallacher J., Francis N.A. Molluscum contagiosum and associations with atopic eczema in children : a retrospective longitudinal study in primary care. Br J Gen Pract. 2016;66:e53-e58.
  • [68] Bansal S., Relhan V., Roy E., Garg V.K., Khurana N. Disseminated molluscum contagiosum in a patient on methotrexate therapy for psoriasis. Indian J Dermatol Venereol Leprol. 2014;80:179-180.
  • [69] Annam V., Inamadar A.C., Palit A., Yelikar B.R. Co-infection of molluscum contagiosum virus and cryptococcosis in the same skin lesion in a HIV-infected patient. J Cutan Pathol. 2008;35:29-31. Suppl 1
  • [70] Smith K.J., Yeager J., Skelton H. Molluscum contagiosum : its clinical, histopathologic, and immunohistochemical spectrum. Int J Dermatol. 1999;38:664-672.
  • [71] Basdag H., Rainer B.M., Cohen B.A. Molluscum contagiosum : to treat or not to treat? Experience with 170 children in an outpatient clinic setting in the northeastern United States. Pediatr Dermatol. 2015;32:353-357.
  • [72] Kose O., Ozmen I., Arca E. An open, comparative study of 10 % potassium hydroxide solution versus salicylic and lactic acid combination in the treatment of molluscum contagiosum in children. J Dermatolog Treat. 2012;24:300-304.
  • [73] Fery-Blanco C., Pelletier F., Humbert P., Aubin F. Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus : efficacy of cidofovir. Ann Dermatol Venereol. 2007;134:457-459.
  • [74] Foissac M., Goehringer F., Ranaivo I.M. Efficacité et tolérance du cidofovir par voie intra-veineuse dans le traitement de molluscums contagiosums géants chez un patient immunodéprimé. Ann Dermatol Venereol. 2014;141:620-622.
  • [75] Drain P.K., Mosam A., Gounder L. Recurrent giantmolluscum contagiosumimmune reconstitution inflammatory syndrome (IRIS) after initiation of antiretroviral therapy in an HIV-infected man. Int J STD AIDS. 2014;25:235-238.   
  • [76] Kalthan E., Dondo-Fongbia J.P., Yambele S. Epidémie de douze cas de maladie à virus monkeypox dans le district de Bangassou en République Centrafricaine en décembre 2015. Bull Soc Pathol Exot. 2016;109:358-363.
  • [77] Fleming S.B., Lyn M., Mercer W., Mercer A.A. Molecular genetic analysis of Orf virus : a poxvirus that has adapted to skin. Viruses. 2015;7:1505-1539.
  • [78] Delaigue S., Morand J.J., Olson D. Teledermatology in Low-Resource Settings : The MSF Experience with a Multilingual Tele-Expertise Platform. Front Public Health. 2014;14:233.